Cargando…

Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease

OBJECTIVE: To evaluate the safety and pharmacokinetic profile of dexlansoprazole modified-release (MR) capsules in pediatric patients with symptomatic gastroesophageal reflux disease (GERD). METHODS: This Phase I, open-label study enrolled male and female patients (1 to 11 years of age) with GERD. P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kukulka, Michael, Nudurupati, Sai, Perez, Maria Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266249/ https://www.ncbi.nlm.nih.gov/pubmed/25525378 http://dx.doi.org/10.2147/CEG.S67672

Ejemplares similares

Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole
por: Kukulka, Michael, et al.
Publicado: (2016)

Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule
por: Kukulka, Michael, et al.
Publicado: (2016)

Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration
por: Kukulka, Michael, et al.
Publicado: (2017)

Bioavailability of dexlansoprazole delayed-release capsule granules when administered via nasogastric tube or orally via syringe
por: Kukulka, Michael, et al.
Publicado: (2018)

Managing gastroesophageal reflux disease – comparative efficacy and outcomes of dexlansoprazole MR
por: Frye, Jeanetta W, et al.
Publicado: (2015)

Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg
por: Kukulka, Michael, et al.
Publicado: (2011)

Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
por: Gold, Benjamin D., et al.
Publicado: (2017)

Phase 4 Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole
por: Wu, Justin C Y, et al.
Publicado: (2020)

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
por: Mermelstein, Joseph, et al.
Publicado: (2016)

Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor – Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region
por: Goh, Khean Lee, et al.
Publicado: (2016)

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Pharmacokinetics of ranitidine in preterm and term neonates with gastroesophageal reflux
por: Asseff, Ismael Lares, et al.
Publicado: (2016)

Surgical Management of Pediatric Gastroesophageal Reflux Disease
por: Jackson, Hope T., et al.
Publicado: (2013)

Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children
por: Malaty, Hoda M, et al.
Publicado: (2009)

Iron Deficiency Anemia in Pediatric Gastroesophageal Reflux Disease
por: Lupu, Vasile Valeriu, et al.
Publicado: (2022)

Impacts of Endoscopic Gastroesophageal Flap Valve Grading on Pediatric Gastroesophageal Reflux Disease
por: Chang, Kai-Chi, et al.
Publicado: (2014)

Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
por: Chiang, Hung-Hsien, et al.
Publicado: (2019)

INFLUENCE OF EXERCISE TESTING IN GASTROESOPHAGEAL REFLUX IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE
por: MENDES-FILHO, Antonio Moreira, et al.
Publicado: (2014)

The role of pH in symptomatic relief and effective treatment of gastroesophageal reflux disease
por: Gąsiorowska, Anita
Publicado: (2017)

Gastroesophageal Reflux Disease
por: Kulkarni, Gaurav V., et al.
Publicado: (2013)

Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents
por: Gremse, David, et al.
Publicado: (2018)

Pharmacokinetic/Pharmacodynamic Evaluation of Dexlansoprazole Infusion Injection Compared with Lansoprazole in Healthy Chinese Adults
por: Wu, Lihua, et al.
Publicado: (2019)

Validation of the Korean Version of the Gastroesophageal Reflux Disease Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease
por: Gong, Eun Jeong, et al.
Publicado: (2019)

Evaluation of gastroesophageal reflux in pediatric laparoscopic appendectomy procedures
por: Bahadır, Gökhan Berktuğ, et al.
Publicado: (2022)

Significance of Extra-Esophageal Symptoms in Pediatric Gastroesophageal Reflux Disease
por: Košec, Andro, et al.
Publicado: (2020)

The relationship between esophageal acidity and symptom frequency in symptomatic nonerosive gastroesophageal reflux disease
por: Gardner, Jerry D.
Publicado: (2022)

Amikacin/dexlansoprazole: Laryngitis: case report
Publicado: (2021)

Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Normal or Varying Degrees of Impaired Renal Function
por: Mayer, Michael, et al.
Publicado: (2014)

Management of gastroesophageal reflux disease in pediatric patients: a literature review
por: Esposito, Ciro, et al.
Publicado: (2015)

Silent Gastroesophageal Reflux Disease
por: Lu, Ching-Liang
Publicado: (2012)

Refractory gastroesophageal reflux disease
por: Subramanian, Charumathi Raghu, et al.
Publicado: (2015)

Gastroesophageal reflux in lockdown
por: Al-Momani, Hafez, et al.
Publicado: (2023)

Safety profile of magnetic sphincter augmentation for gastroesophageal reflux disease
por: Froiio, Caterina, et al.
Publicado: (2023)

Gastroesophageal Reflux Disease and Asthma: A Narrative Review
por: Grandes, Xavier A, et al.
Publicado: (2022)

DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE
por: Henry, Maria Aparecida Coelho de Arruda
Publicado: (2014)

Endoscopic anti-reflux therapy for gastroesophageal reflux disease
por: Rodríguez de Santiago, Enrique, et al.
Publicado: (2021)

Sleeve Gastrectomy and Gastroesophageal Reflux Disease
por: Laffin, Michael, et al.
Publicado: (2013)

Helicobacter pylori and gastroesophageal reflux disease
por: Grande, Michele, et al.
Publicado: (2008)

Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan
por: Sakurai, Kouichi, et al.
Publicado: (2018)

A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection
por: Wu, Deng-Chyang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pj8ggu1e46pmt8bnqvtq7oifo5